ASSERT – An Open Label Study to Evaluate the Long-term Safety and Efficacy of Odevixibat (A4250) in Patients with Alagille Syndrome (ASSERT-EXT)

Biliary Atresia Registry

ASSERT – A Phase 3 double-blind, randomized, Placebo-controlled study of the safety and efficacy of Odevixibat (A4250) in patients with Alagille syndrome

BOLD – A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficiacy and Safety of Odevixibat (A4250) in Children With Biliary Atresia Who Have Undergone a Kasai Hepatoenterostomy